Stacey Shepard
Impact in
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
-
- Urticaria and Related Conditions 2
- Eosinophilic Disorders and Syndromes 2
-
- Dermatology and Skin Diseases 2
- Co-authors
- James D. Rodgers (4 shared papers)Tai‐Yuen Yue (2 shared papers)Laurine G. Galya (2 shared papers)Swamy Yeleswaram (4 shared papers)Brian Metcalf (2 shared papers)Pingli Liu (1 shared paper)Mei Li (1 shared paper)Jiacheng Zhou (1 shared paper)
- Journals
- Organic Letters (2 papers)Blood (1 paper)Drug Metabolism and Disposition (1 paper)Pharmaceutics (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United States
In The Last Decade
Stacey Shepard
8 papers receiving 1.5k citations
Stacey Shepard's Hit Papers
Peers
Comparison fields: 5 of 80
- Genetics 530
- Hematology 347
- Rheumatology 349
- Dermatology 158
- Oncology 413
Countries citing papers authored by Stacey Shepard
This map shows the geographic impact of Stacey Shepard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Shepard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Shepard more than expected).
Fields of papers citing papers by Stacey Shepard
This network shows the impact of papers produced by Stacey Shepard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Shepard. The network helps show where Stacey Shepard may publish in the future.
Co-authors
The 25 scholars most cited alongside Stacey Shepard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms Hit paper breakdown → | 2010 | 710 |
| 2 | 2010 | 388 | |
| 3 | 2009 | 140 | |
| 4 | 2011 | 101 | |
| 5 | 2010 | 96 | |
| 6 | 2015 | 56 | |
| 7 | 2004 | 32 | |
| 8 | 2021 | 22 |
About Stacey Shepard
Stacey Shepard is a scholar working on Rheumatology, Dermatology, Immunology, Genetics and Hematology, having authored 8 papers that have together received 1.5k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (3 papers), Synthetic Organic Chemistry Methods (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Dermatology and Skin Diseases (2 papers), Urticaria and Related Conditions (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Chronic Myeloid Leukemia Treatments (1 paper) and Autoimmune and Inflammatory Disorders Research (1 paper). The work is most often cited by research in Genetics (530 citations), Hematology (347 citations), Rheumatology (349 citations), Dermatology (158 citations) and Oncology (413 citations). Stacey Shepard has collaborated with scholars based in United States. Frequent co-authors include James D. Rodgers, Tai‐Yuen Yue, Laurine G. Galya, Swamy Yeleswaram, Brian Metcalf, Pingli Liu, Mei Li, Jiacheng Zhou, Qiyan Lin and David J. Meloni. Their work appears in journals such as Organic Letters, Blood, Drug Metabolism and Disposition, Pharmaceutics and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.